Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H)
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| PRODIGE 90 - (FFCD 2204) Neoadjuvant Dostarlimab with Short Course Radiotherapy in a Watch-and-wait Strategy for Microsatellite Unstable or Mismatch Repair-deficient Locally Advanced Rectal Cancer Patients (NCT06762405) | Centre Hospitalier Universitaire Dijon | 2025-02-06 |
Track Rectal Adenocarcinoma with Mismatch-repair Deficient (dMMR)/ Microsatellite Instability-high (MSI-H) automatically
Every clearance here is in the API, with alerts when new ones post.